Literature DB >> 16694913

CHEMOTHERAPY OF PNEUMOCOCCIC MENINGITIS WITH SPECIAL REFERENCE TO SULFATHIAZOLE.

F B Cooper1, P Gross, M L Hagan.   

Abstract

Entities:  

Year:  1942        PMID: 16694913      PMCID: PMC435141          DOI: 10.1172/JCI101301

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  4 in total

1.  SULFAPYRIDINE, SULFANILAMIDE, AND SPECIFIC ANTISERUM IN EXPERIMENTAL TYPE III PNEUMOCOCCIC INFECTIONS.

Authors:  F B Cooper; P Gross; M Lewis
Journal:  J Clin Invest       Date:  1939-07       Impact factor: 14.808

2.  BINDING OF SULFONAMIDES BY PLASMA PROTEINS.

Authors:  B D Davis
Journal:  Science       Date:  1942-01-16       Impact factor: 47.728

3.  The Clinical Use of Sulfanilamide, Sulfapyridine, Sulfathiazole, Sulfaguanidine, and Sulfadiazine in the Prophylaxis and Treatment of Infections.

Authors:  P H Long
Journal:  Can Med Assoc J       Date:  1941-03       Impact factor: 8.262

4.  Repair in experimental pneumococcic meningitis: A histopathological study of residual lesions in rats.

Authors:  P Gross; F B Cooper; M Lewis
Journal:  Am J Pathol       Date:  1939-03       Impact factor: 4.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.